1-2 of 2
David Margolis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia

Andrew H. Matthews, Alexander E. Perl, Selina M. Luger, Alison W. Loren, Saar I. Gill, David L. Porter, Daria V. Babushok, Ivan P. Maillard, Martin P. Carroll, Noelle V. Frey, Elizabeth O. Hexner, Mary Ellen Martin, Shannon R. McCurdy, Edward A. Stadtmauer, Vikram R. Paralkar, Ximena Jordan Bruno, Wei-Ting Hwang, David Margolis, Keith W. Pratz
Journal: Blood Advances
Blood Adv (2022) 6 (13): 3997–4005.
https://doi.org/10.1182/bloodadvances.2022007265
Published: 2022
Includes: Supplemental data
Journal Articles

Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis

Clinical Trials & Observations
Larisa Broglie, Lauren Pommert, Sridhar Rao, Monica Thakar, Rachel Phelan, David Margolis, Julie Talano
Journal: Blood Advances
Blood Adv (2017) 1 (19): 1533–1536.
https://doi.org/10.1182/bloodadvances.2017007526
Published: 2017